Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 5,887 | 713 | 5,084 |
| Samples | 1,706 | 297 | 1,379 |
| Peptides | 1,541 | 246 | 1,319 |
Function
TRRAP · Transformation/transcription domain associated protein
This gene encodes a large multidomain protein of the phosphoinositide 3-kinase-related kinases (PIKK) family. The encoded protein is a common component of many histone acetyltransferase (HAT) complexes and plays a role in transcription and DNA repair by recruiting HAT complexes to chromatin. Deregulation of this gene may play a role in several types of cancer including glioblastoma multiforme. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Sep 2011].
Isoforms & Proteins
4 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 1405 amino-acid changes on canonical ENST00000359863 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in TRRAP · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in TRRAP – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Lymphoblastic Leukemia | 13/40 32% | 0/0 0% |
| T-Cell Non-Hodgkins Lymphoma | 5/26 19% | 0/0 0% |
| Chronic Myelogenous Leukemia | 4/25 16% | 0/0 0% |
| Endometrial Carcinoma | 12/42 29% | 76/612 12% |
| Melanoma | 30/210 14% | 197/1899 10% |
| Bladder Carcinoma | 9/58 16% | 69/956 7% |
| Colorectal Carcinoma | 41/143 29% | 197/3239 6% |
| Gastric Carcinoma | 12/74 16% | 117/1809 6% |
| Neuroendocrine Tumour | 28/154 18% | 15/577 3% |
| Other Solid Cancers | 2/94 2% | 86/1515 6% |
| Non-Small Cell Lung Carcinoma | 25/304 8% | 67/1390 5% |
| Thymic Epithelial Tumor | 0/0 0% | 2/39 5% |
| Cervical Carcinoma | 2/35 6% | 21/422 5% |
| Squamous Cell Lung Carcinoma | 7/57 12% | 32/810 4% |
| Germ Cell Tumour | 3/25 12% | 5/169 3% |
| Hodgkins Lymphoma | 4/16 25% | 1/122 1% |
| Head and Neck Carcinoma | 5/85 6% | 47/1574 3% |
| Non-Cancerous | 6/104 6% | 22/830 3% |
| Ovarian Carcinoma | 11/109 10% | 22/998 2% |
| Rhabdomyosarcoma | 3/33 9% | 3/171 2% |
| Other Sarcomas | 4/69 6% | 17/699 2% |
| Burkitts Lymphoma | 4/32 12% | 2/196 1% |
| Unknown | 0/10 0% | 1/29 3% |
| Hepatocellular Carcinoma | 4/46 9% | 53/2210 2% |
| Small Cell Lung Carcinoma | 0/9 0% | 18/752 2% |
| Esophageal Carcinoma | 0/23 0% | 18/769 2% |
| Ewings Sarcoma | 3/63 5% | 4/262 2% |
| Esophageal Squamous Cell Carcinoma | 8/51 16% | 47/2550 2% |
| Osteosarcoma | 3/45 7% | 1/166 1% |
| Kidney Carcinoma | 4/85 5% | 32/1862 2% |
Mutation Distribution
Where TRRAP is mutated · all tissues, split by cell line vs tissue
How many mutations in TRRAP were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 5,887 mutations in TRRAP
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|